Nanotherapeutics for enhancing thermal therapy of cancer.

作者: Rachana Visaria , John C. Bischof , Melissa Loren , Brent Williams , Emad Ebbini

DOI: 10.1080/02656730701611241

关键词:

摘要: Purpose: The current work describes the synergistic enhancement of hyperthermic cancer therapy by selective thermal sensitization and induction vascular injury at tumor site. specificity this response was mediated CYT-6091: a pegylated colloidal gold-based nanotherapeutic designed to selectively deliver an inflammatory cytokine, necrosis factor alpha (TNF), solid tumors.Materials methods: FSaII murine fibrosarcoma-bearing C3H mice received intravenous injection either soluble TNF or CYT-6091 (50–250 µg/kg TNF). Four hours later tumors were exposed localized heating (42.5 43.5°C, 60 min). Tumor responses assessed growth delay and/or perfusion.Results: Both reduced perfusion 80% control (no treatment), 4 post administration. However, toxic burdened resulted in 40% mortality alone 100% when combined with hyperthermia. Conversely, no toxicities noted CY...

参考文章(44)
Hiroshi Neda, Ichiro Urushizaki, Yoshiro Niitsu, Naoki Watanabe, Naofumi Yamauchi, Masahiro Maeda, Hiroshi Kuriyama, Hiroshi Umeno, Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Research. ,vol. 48, pp. 2179- 2183 ,(1988)
Raghav Goel, David Swanlund, James Coad, Guilio F. Paciotti, John C. Bischof, TNF-α–based accentuation in cryoinjury—dose, delivery, and response Molecular Cancer Therapeutics. ,vol. 6, pp. 2039- 2047 ,(2007) , 10.1158/1535-7163.MCT-06-0676
Giulio F. Paciotti, Lonnie Myer, David Weinreich, Dan Goia, Nicolae Pavel, Richard E. McLaughlin, Lawrence Tamarkin, COLLOIDAL GOLD: A NOVEL NANOPARTICLE VECTOR FOR TUMOR DIRECTED DRUG DELIVERY Drug Delivery. ,vol. 11, pp. 169- 183 ,(2004) , 10.1080/10717540490433895
Philip E. Thorpe, Vascular Targeting Agents as Cancer Therapeutics Clinical Cancer Research. ,vol. 10, pp. 415- 427 ,(2004) , 10.1158/1078-0432.CCR-0642-03
Remco van Horssen, Timo L. M. ten Hagen, Alexander M. M. Eggermont, TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist. ,vol. 11, pp. 397- 408 ,(2006) , 10.1634/THEONCOLOGIST.11-4-397
J. Overgaard, D. Gonzalez Gonzalez, M. C. C. H. Hulshof, G. Arcangeli, O. Dahl, O. Mella, S. M. Bentzen, Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology International Journal of Hyperthermia. ,vol. 12, pp. 3- 20 ,(1996) , 10.3109/02656739609023685
Ralph Weichselbaum, Nader Hanna, Neil Senzer, Sridhar Mani, Alexander Rosemurgy, John Nemunaitis, Casey Cunningham, Chandan Guha, Natalia Bayol, Michelle Gillen, Karen Chu, Camilla Rasmussen, Henrik Rasmussen, Donald Kufe, TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors. Journal of Clinical Oncology. ,vol. 22, pp. 592- 601 ,(2004) , 10.1200/JCO.2004.01.227
R J. Griffin, K. Okajima, A. Ogawa, CW Song, Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing. International Journal of Radiation Biology. ,vol. 75, pp. 1299- 1306 ,(1999) , 10.1080/095530099139467
Dezheng Dong, Bryce Ko, Peter Baumeister, Steven Swenson, Fritz Costa, Frank Markland, Caryn Stiles, John B. Patterson, Susan E. Bates, Amy S. Lee, Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment. Cancer Research. ,vol. 65, pp. 5785- 5791 ,(2005) , 10.1158/0008-5472.CAN-05-0754
M. Morita, H. Kuwano, H. Matsuda, M. Mori, K. Sugimachi, Increased hyperthermic response with prostaglandin E1 in VX2 liver carcinoma in rabbits. Journal of the National Cancer Institute. ,vol. 83, pp. 1395- 1400 ,(1991) , 10.1093/JNCI/83.19.1395